Noticias

Noticias

  • Título: Terumo signs to acquire St Jude Medical and Abbott’s vascular closure business
  • Fecha: 07-12-2016

  • TOKYO, JAPAN – Dec. 7, 2016 -- Terumo Corporation (TSE: 4543) announced today that it has reached an agreement with Abbott and St. Jude Medical, Inc. to acquire certain products owned by both for a total of US$1.12 billion.


    Based on an agreement in principle previously announced by Terumo, Abbott and St. Jude Medical on October 18, 2016, Terumo will acquire St Jude Medical’s Angio-Seal™ and FemoSeal™ vascular closure product lines and Abbott’s Vado™ Steerable Sheath. The total annual sales of the businesses to be acquired is approximately US$268 million.


    Terumo supplies a range of interventional access devices, including introducer sheaths and guide wires, and has a broad global customer base. “The acquisition, which brings us leading vascular closure devices, will enable Terumo to provide customers with a comprehensive product offering in minimally invasive entry site management and lesion access,” said Yutaro Shintaku, President and CEO of Terumo Corporation. “We expect that the acquisition will enhance our presence in the United States, which is the largest market for medical devices.”


    By building on Terumo’s existing infrastructure and competencies, the acquisition will enable Terumo to maximize the value of the acquired businesses and contribute to supporting safe and efficient interventional procedures.


    The acquisition remains subject to antitrust regulatory approvals and successful completion of Abbott’s proposed acquisition of St. Jude Medical.



  • Fuente: endovascular.es